Novartis Q3 Results and Pipeline Progress
Novartis, an innovative medicines company, delivers solid sales and core operating income growth with strong pipeline progress in Q3 and reaffirms FY 2025 guidance.
Our Mission
Novartis works to reimagine medicine, improving and extending people's lives, empowering patients, healthcare professionals, and societies in the face of serious disease.
Global Reach
Our medicines reach 296 million people worldwide, providing access to innovative treatments.
Resources
- Clinical trial recruiting and managed access programs for patients and caregivers
- Grant funding, congresses, and country-level information for healthcare professionals
Discover how Novartis turns breakthrough science into transformative, high-value treatments.
Learn about our commitments to making a positive impact on the world through the Novartis in Society Integrated Report, focusing on access to innovative medicines, environmental protection, and upholding high ethical standards.
Author's summary: Novartis delivers solid Q3 results.
More News
- Suspect in Charlie Kirk killing can wear street clothes in court amid ‘extraordinary’ attention | Fulton Sun
- Hero Seekers is an upcoming fantasy RPG set in a world where no one remembers the good guys
- Justice unveils blueprint to cut remand population
- Cisco and G42 Deepen US-UAE Technology Partnership to Build Secure, End-to-End AI Infrastructure in the UAE
- The Coming Dementia Crisis—and the Cost of Doing Nothing